Bracco and Avicenna.AI Announce FDA Clearance for UPTUNITY™ | Aneurysm, a New AI-Enabled Software for Brain Aneurysm Detection and Assessment

Developed in collaboration with Avicenna.AI, the newly FDA-cleared technology introduces UPTUNITY™, Bracco’s new portfolio of AI-enabled clinical decision support solutions. MILAN, Nov. 13, 2026 /PRNewswire/ — Bracco and Avicenna.AI today announced U.S. Food and Drug Administration (FDA)…

About the Author

has written 42615 stories on this site.

Copyright © 2010 Business and Corporate News.